Alfian Nur Rosyid, MD, PhD is an expert in Infectiology at Airlangga University (Indonesia). As of September 2026, ScienceLeadR ranks Alfian Nur Rosyid in the top 1% of experts in Indonesia for Pneumonia, COVID-19 and Coronavirus Infections. Alfian Nur Rosyid has authored 71 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 211 (community average: 125). How the SLR is computed.

LeadR Profile

Alfian Nur Rosyid, MD, PhD Airlangga University Indonesia
211 ScienceLeadR Reputation 211
Network Map

Infectiology

Subspecialties: Pulmonology - Surgery - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2015 - 2026

Source: PubMed

Universitas Airlangga Fakultas Kedokteran

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 71

Citations

Citations: 338 1st author: 14 Last author: 17 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Serum fibrinogen levels and lung fibrosis in COVID-19 patients.
PMID 42112733 — lung, serum, fibrosis, biopsy, covid-19, fibrinogen, fibrin
J Infect Dev Ctries20260
Artificial intelligence-based chest X-ray (AI-CXR) and hematology parameters to predict mortality and intubation events In COVID-19 patients at the second-referral hospital in Indonesia.
PMID 41826850 — intelligence, intubation, mortality, hematology, covid-19, artificial intelligence, communicable diseases
BMC Infect Dis20260
Profiling High-risk Chronic Obstructive Pulmonary Disease Patients for Triple Therapy: Who Needs It Most?
PMID 41656186 — quality of life, comorbidity, eosinophils, spirometry, pulmonary disease, chronic obstructive, morbidity, therapeutics, lung diseases, lung diseases, obstructive
Ann Afr Med20260
From Inoperable to Remission: Complete Response in Advanced Thymoma B3 With Immunotherapy-A Case Report.
PMID 41378362 — radiotherapy, thymoma, thymectomy, immunotherapy
Respirol Case Rep20250
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
PMID 40886716 — mortality, safety, serum, vaccines, recycling, aged, covid-19, pneumonia, therapeutics, communicable diseases
Lancet Infect Dis20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map